Results 251 to 260 of about 155,399 (295)

Artificial intelligence based prediction of first recurrence in neovascular age related macular degeneration with validation by 19 experts. [PDF]

Sci Rep
Jang B, Lee CH, Kim SJ, Yoon CK, Park UC, Choi J, Lee EK, Kim YG.   +7 more
europepmc   +1 more source

A multi-paradigm, whole system view of health and social care for age-related macular degeneration

, 2012
Brailsford, S.C., Channon, Andrew A.R., Lotery, Andrew, Rossiter, Stuart P., Viana, Joe   +4 more
core   +1 more source

Impacts of cataract surgery in eyes treated by anti-vascular endothelial growth factor therapy for wet age-related macular degeneration on visual outcomes

, 2019
Tomohiro Obayashi, Tsutomu Yasukawa, Ryoko Takeuchi, Miho Inagaki, Katsuya Suzuki, Noriaki Takase, Naomi Inoue, Aki Kato, Hiroshi Morita, Yoshio Hirano, Miho Nozaki, Munenori Yoshida, Yuichiro Ogura   +12 more
openalex   +1 more source

Association between age-related macular degeneration and osteoporosis in US. [PDF]

Sci Rep
Liu S, Zhang O, Wang H, Zhou S, Luo P.
europepmc   +1 more source

Epigenetic Alterations in Age-Related Macular Degeneration: Mechanisms and Implications. [PDF]

Int J Mol Sci
Kisswani D, Carroll C, Valdes-Mora F, Rutar M.   +3 more
europepmc   +1 more source

Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration: XTEND at 3 Years.

Ophthalmologica
Korobelnik JF, Chaudhary V, Mitchell P, Kang SW, Allmeier H, Lee J, Zhang X, Machewitz T, Bailey C.   +8 more
europepmc   +1 more source

Preserved Contrast Sensitivity in Early and Intermediate Age-Related Macular Degeneration and Marked Loss in Late Stage: ALSTAR2. [PDF]

Invest Ophthalmol Vis Sci
Owsley C, Gao L, Gooden L, Thomas TN, Pu J, Crosson JN, Curcio CA, McGwin G, Kwon M.   +8 more
europepmc   +1 more source

Anti-vascular endothelial growth factor (anti-VEGF) agents for neovascular age-related macular degeneration (nAMD): a network meta-analysis. [PDF]

Cochrane Database Syst Rev
Lucenteforte E, Ng SM, Saulle R, Hoad G, Schillinger R, Virgili G.   +5 more
europepmc   +1 more source